News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
US FDA Sets Stricter Approval Standards for COVID-19 Vaccine Boosters; Moderna Soars 6%
The U.S. Food and Drug Administration (FDA) announced new regulatory guidelines for COVID-19 vaccine boosters on Tuesday, establishing stricter approval standards for Americans. Th...
Reset
Send
The window will close in 5 seconds
US FDA Sets Stricter Approval Standards for COVID-19 Vaccine Boosters; Moderna Soars 6%
Close
Recommend
3
Positive
5
Negative
1
 
SHORT SELL
 
STOCK INFO

The U.S. Food and Drug Administration (FDA) announced new regulatory guidelines for COVID-19 vaccine boosters on Tuesday, establishing stricter approval standards for Americans.

The FDA hopes to see new clinical trials proving that COVID-19 vaccines remain safe and effective before approving them for healthy adults and children.

Related NewsTrump Says He's Willing to Visit CN to Discuss Diplomatic & Economic Issues with Xi
This will be a costly new requirement for pharmaceutical companies and may limit the number of new vaccines administered each year.

The news bolstered vaccine stocks, with Moderna (MRNA.US)      up 6%, and BioNTech (BNTX.US)      and Novavax (NVAX.US)      up 1-2%.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.